[1] Ziaee M,Azarkar G.Prevalence of hepatitis d virus infection among patients with chronic hepatitis B attending birjand hepatitis clinic(East of Iran) in 2012[J].Hepat Mon,2013,13(8):e11168.
[2] Liaw YF,Chu CM.Hepatitis B virus infection[J].Lancet,2009,37(63):582-592.
[3] Ocama P,Opio CK,Lee WM.Hepatitis B virus infection:current status[J].Am J Med,2005,118(12):1413.
[4] Kosaka K,Hiraga N,Imamura M,et al.A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections[J].Biochem Biophys Res Commun,2013(13):1712-1719.
[5] McMahon BJ.Epidemiology and natural history of hepatitis B[J].Semin Liver Dis,2005,25(Suppl 1):3-8.
[6] Yuen MF,Tanaka Y,Fong DY,et al.Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B[J].J Hepatol,2009,15(10):80-88.
[7] El-Serag HB,Rudolph KL.Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J].Gastroenterology,2007,13(7):2557-2576.
[8] 章晓联.病毒免疫学[M].北京:科学出版社,2010:165-172.
[9] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南2010年更新版[J].中华实验和临床感染病杂志,2011,5(1):70-100.
[10] 中华医学会传染病与寄生虫病学分会,中华医学会肝病分会.病毒性肝炎防治方案[J].传染病信息,2000,13(4):141-150.
[11] 曹雪涛.免疫学技术及其应用[M].北京:科学出版社,2010:3-4.
[12] 杨炼,管小琴,陈显兵.HBV感染对人体T细胞免疫功能影响的研究[J].重庆医科大学学报,2005,30(4):552-555.
[13] 叶国强,朱美玲.HBV感染者外周血T淋巴细胞亚群分析[J].中华综合医学杂志,2004,6(2):8-9.
[14] Vassilopoulos D,Rapti I,Nikolaou M,et al.Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B[J].J Viral Hepat,2008,15(11):817-826.